The Medicines Company (NASDAQ:MDCO): President & CFO Glenn Sblendorio Sold 125,000 Shares
President and CFO Glenn Sblendorio sold 125,000 shares of MDCO stock on 01/16/2013 at the average price of $30. Glenn Sblendorio owns at least 97,282 shares after this. The price of the stock has increased by 0.33% since.
The Medicines Company was incorporated in Delaware on July 31, 1996. Medicines has a market cap of $1.63 billion; its shares were traded at around $30.1 with a P/E ratio of 33.3 and P/S ratio of 3.14.
The Medicines Company reported third quarter 2012 revenue increase of 13.3% year-over-year to $136.8 million, and GAAP net income decrease to $9.3 million ($0.17 per share) from $72.6 million ($1.34 per share) prior year quarter. Third quarter 2011 GAAP income included a $66.5 million benefit for income taxes. Non-GAAP net income was $21.8 million compared to $9.2 million last year.
Chairman and CEO Clive Meanwell sold 2,500 shares of MDCO stock on 01/16/2013 at the average price of $30. Director Robert G. Savage and Chief Accounting Officer William Bernard O'Connor both also sold shares of MDCO stock recently.
Signet Jewelers Ltd. (NYSE:SIG): U.S. CFO Robert Trabucco Sold 28,411 Shares
U.S. CFO Robert Trabucco sold 28,411 shares of SIG stock on 01/16/2013 at the average price of $59.55. Robert Trabucco owns at least 22,274 shares after this. The price of the stock has increased by 2.84% since.
Signet Jewelers Ltd. is a retailer of jewelry, watches and associated services. Signet Jewelers Ltd. has a market cap of $4.96 billion; its shares were traded at around $61.24 with a P/E ratio of 14.99 and P/S ratio of 1.35. The dividend yield of Signet Jewelers Ltd. stocks is 0.75%.
For its third quarter 2013 ended Oct. 27, 2012, Signet Jewelers reported diluted EPS of $0.43 – up 43.3% from prior year quarter. Same store sales were up 1.4% from prior year quarter, and gross margin went up 50 basis points to 32.9% of sales. Operating income was $52.5 million, up 23.5% from last year.
US COO Edward Hrabak sold 8,048 shares of SIG stock on 01/17/2013 at the average price of $60.7.
Valassis Communications Inc. (NYSE:VCI): Executive Vice President and CFO Robert L. Recchia Sold 26,400 Shares
Executive Vice President and CFO Robert L. Recchia sold 26,400 shares of VCI stock on 01/10/2013 at the average price of $27.34. Robert L. Recchia owns at least 130,069 shares after this. The price of the stock has increased by 2.34% since.
Valassis Communications Inc. is a Delaware Corporation. Valassis Communications Inc. has a market cap of $1.1 billion; its shares were traded at around $27.98 with a P/E ratio of 10.13 and P/S ratio of 0.55. The dividend yield of Valassis Communications Inc. stocks is 1.11%.
Valassis Communications Inc. reported third quarter 2012 EPS of $0.90, improving by 55.2% from the third quarter of 2011. Net revenue decreased by 0.9% to $523.8 million, but operating profits grew by 20.3% to $58.9 million due to a decrease in expenses.
PhotoMedex Inc. (NASDAQ:PHMD): President and CFO Dennis M. McGrath Sold 17,699 Shares
President and CFO Dennis M. McGrath sold 17,699 shares of PHMD stock on 01/15/2013 at the average price of $15. Dennis M. McGrath owns at least 233,857 shares after this. The price of the stock has increased by 1.13% since.
PhotoMedex Inc. is a Nevada corporation incorporated in 2010. PhotoMedex Inc. has a market cap of $326.255 million; its shares were traded at around $15.17 with a P/E ratio of 20.53 and P/S ratio of 1.43.
PhotoMedex Inc. has released its third quarter 2012 results. For this quarter, the company reported revenues of $56.7 million, an increase of 63% over prior year quarter. Net income was $7.5 million ($0.35 per diluted share), compared to $4.2 million ($0.32 per share) in the same quarter of last year.
CEO, 10% Owner Dolev Rafaeli sold 172,516 shares of PHMD stock on 01/15/2013 at the average price of $15.
Synopsys (NASDAQ:SNPS): CFO Brian M. Beattie Sold 17,500 Shares
CFO Brian M. Beattie sold 17,500 shares of SNPS stock on 01/15/2013 at the average price of $32.26. Brian M. Beattie owns at least 20,130 shares after this. The price of the stock has decreased by 0.12% since.
Synopsys was incorporated in 1986 in North Carolina and reincorporated in Delaware in 1987. Synopsys has a market cap of $4.87 billion; its shares were traded at around $32.22 with a P/E ratio of 26.6667 and P/S ratio of 2.7594. Synopsys had an annual average earnings growth of 12.9% over the past 10 years. GuruFocus rated Synopsys the business predictability rank of 2.5-star.
Synopsys delivered fourth quarter 2012 revenue of $454.2 million, and GAAP net income of $29.1 million ($0.19 per share), compared to last year’s $390.5 million and $39.9 million ($0.27 per share), respectively.
Director Deborah A. Coleman sold 70,000 shares of SNPS stock on 01/17/2013 at the average price of $32.50.
For the complete list of stocks that were sold by their CFOs, go to: Insider Buys.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.